The Effects of Inositol on Glucose Metabolism in Patients with Metabolic Syndrome At Risk of Cardiac Fibrosis

Not Applicable

Recruiting

• Conditions: Cardiac Fibrosis; Metabolic Syndrome
• Interventions: Dietary Supplement: Inositol and alpha-lactalbumin

• Registration Number: NCT05689710
• Lead Sponsor: Lo.Li.Pharma s.r.l

Brief Summary

The study aims to evaluate the effects of an oral supplementation based on inositols and alpha-lactalbumin on principals metabolic parameters in patients with metabolic syndrome at risk of cardiac fibrosis

Detailed Description

Not available

Study Timeline

• Study Start: 2022-12-23
• Study First Submitted: 2022-12-23
• Study First Submitted QC: 2023-01-10
• Study First Posted: 2023-01-19
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-18
• Last Update Posted: 2025-02-20
• Primary Completion: 2025-08
• Study Completion: 2026-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental	Inositol and alpha-lactalbumin	Dietary Supplement with inositols and alpha-lactalbumin

Primary Outcome Measures

Name	Time	Method
Body weight	Four time points: changes in body weight (kg) from the baseline to 30, 90, 180 days

Secondary Outcome Measures

Name	Time	Method
Tryglicerides	Four time points: changes in blood levels of tryglycerides from the baseline to 30, 90, 180 days	Plasmatic levels of tryglicerides
Hypertension	Four time points: changes in values of systolic and diastolic blood pressure from the baseline to 30, 90, 180 days	sphygmomanometer

Trial Locations

Locations (1)

UOC Medicina Interna e Nefrologia P.O. AQ; 🇮🇹 L'Aquila, Italy